BBP was created on 2014-12-17 by Virtus. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 73.36m in AUM and 60 holdings. BBP tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider.